Related references
Note: Only part of the references are listed.Neuroinflammation, Microglia and Mast Cells in the Pathophysiology of Neurocognitive Disorders: A Review
Stephen Skaper et al.
CNS & Neurological Disorders-Drug Targets (2015)
Interferon Lambda Upregulates IDO1 Expression in Respiratory Epithelial Cells After Influenza Virus Infection
Julie M. Fox et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2015)
Neuroprotective effect of masitinib in rats with postischemic stroke
Ivan Kocic et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2015)
Putative Neuroprotective and Neurotoxic Kynurenine Pathway Metabolites Are Associated with Hippocampal and Amygdalar Volumes in Subjects with Major Depressive Disorder
Jonathan Savitz et al.
NEUROPSYCHOPHARMACOLOGY (2015)
A tryptophan metabolite, kynurenine, promotes mast cell activation through aryl hydrocarbon receptor
H. Kawasaki et al.
ALLERGY (2014)
Insights from interferon-α-related depression for the pathogenesis of depression associated with inflammation
Carolina Hoyo-Becerra et al.
BRAIN BEHAVIOR AND IMMUNITY (2014)
Targeting classical IL-6 signalling or IL-6 trans-signalling in depression?
Michael Maes et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2014)
Mast cells, glia and neuroinflammation: partners in crime?
Stephen D. Skaper et al.
IMMUNOLOGY (2014)
Neuropsychological Features of Adult Mastocytosis
Daniela S. Moura et al.
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA (2014)
Diagnostic Criteria and Classification of Mastocytosis in 2014
Cem Akin et al.
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA (2014)
Mastocytosis
Melody C. Carter et al.
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA (2014)
Dynamic microglial alterations underlie stress-induced depressive-like behavior and suppressed neurogenesis
T. Kreisel et al.
MOLECULAR PSYCHIATRY (2014)
Microglia and brain macrophages in the molecular age: from origin to neuropsychiatric disease
Marco Prinz et al.
NATURE REVIEWS NEUROSCIENCE (2014)
The neuroimmune basis of fatigue
Robert Dantzer et al.
TRENDS IN NEUROSCIENCES (2014)
The serotonin-N-acetylserotonin-melatonin pathway as a biomarker for autism spectrum disorders
C. Pagan et al.
TRANSLATIONAL PSYCHIATRY (2014)
The role of mast cells in neuroinflammation
Sofie Nelissen et al.
ACTA NEUROPATHOLOGICA (2013)
Aryl hydrocarbon receptor controls murine mast cell homeostasis
Yufeng Zhou et al.
BLOOD (2013)
Connecting Inflammation with Glutamate Agonism in Suicidality
Sophie Erhardt et al.
NEUROPSYCHOPHARMACOLOGY (2013)
NMDA Receptor Blockade by Ketamine Abrogates Lipopolysaccharide-Induced Depressive-Like Behavior in C57BL/6J Mice
Adam K. Walker et al.
NEUROPSYCHOPHARMACOLOGY (2013)
Mast cells on the mind: new insights and opportunities
Rae Silver et al.
TRENDS IN NEUROSCIENCES (2013)
A Randomized Controlled Trial of the Tumor Necrosis Factor Antagonist Infliximab for Treatment-Resistant Depression
Charles L. Raison et al.
JAMA PSYCHIATRY (2013)
Ketamine for Depression: Where Do We Go from Here?
Marije Aan Het Rot et al.
BIOLOGICAL PSYCHIATRY (2012)
Depression and sickness behavior are Janus-faced responses to shared inflammatory pathways
Michael Maes et al.
BMC MEDICINE (2012)
Targeting IL-1 in depression
Michael Maes et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2012)
The Aryl Hydrocarbon Receptor Modulates Acute and Late Mast Cell Responses
Riccardo Sibilano et al.
JOURNAL OF IMMUNOLOGY (2012)
The role of the kynurenine metabolism in major depression
Aye-Mu Myint et al.
JOURNAL OF NEURAL TRANSMISSION (2012)
Kynurenines in the mammalian brain: when physiology meets pathology
Robert Schwarcz et al.
NATURE REVIEWS NEUROSCIENCE (2012)
Psychoneuroimmunology Meets Neuropsychopharmacology: Translational Implications of the Impact of Inflammation on Behavior
Ebrahim Haroon et al.
NEUROPSYCHOPHARMACOLOGY (2012)
Evidence for Cognitive Impairment in Mastocytosis: Prevalence, Features and Correlations to Depression
Daniela Silva Moura et al.
PLOS ONE (2012)
Blood CD34-c-Kit+ cell rate correlates with aggressive forms of systemic mastocytosis and behaves like a mast cell precursor
Sophie Georgin-Lavialle et al.
BLOOD (2011)
Citalopram reduces endotoxin-induced fatigue
Jonas Hannestad et al.
BRAIN BEHAVIOR AND IMMUNITY (2011)
Severe depression is associated with increased microglial quinolinic acid in subregions of the anterior cingulate gyrus: Evidence for an immune-modulated glutamatergic neurotransmission?
Johann Steiner et al.
JOURNAL OF NEUROINFLAMMATION (2011)
Depression in Patients with Mastocytosis: Prevalence, Features and Effects of Masitinib Therapy
Daniela Silva Moura et al.
PLOS ONE (2011)
Immune system to brain signaling: Neuropsychopharmacological implications
Lucile Capuron et al.
PHARMACOLOGY & THERAPEUTICS (2011)
The new '5-HT' hypothesis of depression: Cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression
M. Maes et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2011)
Depression is an inflammatory disease, but cell-mediated immune activation is the key component of depression
Michael Maes
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2011)
EFFECTS OF THE α7 NICOTINIC ACETYLCHOLINE RECEPTOR AGONIST GTS-21 ON THE INNATE IMMUNE RESPONSE IN HUMANS
Matthijs Kox et al.
SHOCK (2011)
CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-α: relationship to CNS immune responses and depression
C. L. Raison et al.
MOLECULAR PSYCHIATRY (2010)
A critical review of human endotoxin administration as an experimental paradigm of depression
Nicole DellaGioia et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2010)
Neural Origins of Human Sickness in Interoceptive Responses to Inflammation
Neil A. Harrison et al.
BIOLOGICAL PSYCHIATRY (2009)
Mechanisms of cytokine-induced behavioral changes: Psychoneuroimmunology at the translational interface
Andrew H. Miller
BRAIN BEHAVIOR AND IMMUNITY (2009)
Does cytokine-induced depression differ from idiopathic major depression in medically healthy individuals?
Lucile Capuron et al.
JOURNAL OF AFFECTIVE DISORDERS (2009)
Interferon-γ and Tumor Necrosis Factor-α Mediate the Upregulation of Indoleamine 2,3-Dioxygenase and the Induction of Depressive-Like Behavior in Mice in Response to Bacillus Calmette-Guerin
Jason C. O'Connor et al.
JOURNAL OF NEUROSCIENCE (2009)
Clinical correlates of blood serotonin levels in patients with mastocytosis
N. M. Kushnir-Sukhov et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2008)
Indoleamine 2,3-dioxygenase in T-cell tolerance and tumoral immune escape
Jessica B. Katz et al.
IMMUNOLOGICAL REVIEWS (2008)
From inflammation to sickness and depression: when the immune system subjugates the brain
Robert Dantzer et al.
NATURE REVIEWS NEUROSCIENCE (2008)
Case-Control Cohort Study of Patients' Perceptions of Disability in Mastocytosis
Olivier Hermine et al.
PLOS ONE (2008)
Brain mast cells link the immune system to anxiety-like behavior
Katherine M. Nautiyal et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Effects of etanercept therapy on fatigue and symptoms of depression in subjects treated for moderate to severe plaque psoriasis for up to 96 weeks
R. Krishnan et al.
BRITISH JOURNAL OF DERMATOLOGY (2007)
Brain mast cell relationship to neurovasculature during development
Mona Khalil et al.
BRAIN RESEARCH (2007)
Assessment of tumor necrosis factor alpha blockade as an intervention to improve tolerability of dose-intensive chemotherapy in cancer patients
JP Monk et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial
S Tyring et al.
LANCET (2006)
Neuroimmunoendocrine circuitry of the 'brain-skin connection'
R Paus et al.
TRENDS IN IMMUNOLOGY (2006)
Low-dose endotoxemia and human neuropsychological functions
KS Krabbe et al.
BRAIN BEHAVIOR AND IMMUNITY (2005)
IDO and interferon-α-induced depressive symptoms:: a shift in hypothesis from tryptophan depletion to neurotoxicity
MC Wichers et al.
MOLECULAR PSYCHIATRY (2005)
Neuropsychiatric adverse effects of interferon-alpha - Recognition and management
CL Raison et al.
CNS DRUGS (2005)
Depression during pegylated interferon-alpha plus ribavirin therapy: Prevalence and prediction
CL Raison et al.
JOURNAL OF CLINICAL PSYCHIATRY (2005)
Critical role of mast cells in inflammatory diseases and the effect of acute stress
TC Theoharides et al.
JOURNAL OF NEUROIMMUNOLOGY (2004)
Depression induced by treatment with interferon-alpha in patients affected by hepatitis C virus
S Bonaccorso et al.
JOURNAL OF AFFECTIVE DISORDERS (2002)
Validity of the Beck Depression Inventory, Hospital Anxiety and Depression Scale, SCL-90, and Hamilton depression rating scale as screening instruments for depression in stroke patients
I Aben et al.
PSYCHOSOMATICS (2002)
Cytokine-associated emotional and cognitive disturbances in humans
A Reichenberg et al.
ARCHIVES OF GENERAL PSYCHIATRY (2001)
Paroxetine for the prevention of depression induced by high-dose interferon alfa
DL Musselman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Acute stress increases permeability of the blood-brain-barrier through activation of brain mast cells
P Esposito et al.
BRAIN RESEARCH (2001)
Share Paper
